Earnings Dr Reddy's Labs Q4FY20 profit jumps 76%, announces dividend of Rs 25/share Updated : May 21, 2020 09:19 AM IST EBITDA in Q4FY20 was at Rs 1,001 crore while EBITDA margin came in at 22.6 percent. margin came in at 22.6 percent. The company's global generics segment revenue reported a 20 percent rise to Rs 3,639.8 crore from 3,038.4 crore, YoY. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.